Loading...

CL: Future Cost Optimization Will Drive Competitive Advantage Amid Category Headwinds

Published
18 Jul 24
Updated
15 Dec 25
Views
337
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-13.1%
7D
-1.5%

Author's Valuation

US$87.219.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 15 Dec 25

CL: Emerging Market Strength Will Support Gradual Recovery As Q3 Softness Fades

Analysts have trimmed their price target on Colgate-Palmolive to $87 from the low-to-mid $90s, reflecting near term softness in Q3 results and muted personal care growth, even as they expect organic sales momentum to gradually improve.

Analyst Commentary

Analysts remain divided on Colgate-Palmolive, with recent target cuts reflecting near term execution risk, while longer term growth and margin recovery expectations stay largely intact.

Bullish Takeaways

  • Bullish analysts argue that Q3 represents a trough in performance, with easier comparisons and fading temporary headwinds expected to support a gradual reacceleration in organic sales growth.
  • Despite lower price targets, the maintenance of positive ratings signals confidence that the current valuation already discounts much of the near term softness in personal care and household products.
  • Colgate-Palmolive's strong global brand equity and advantaged presence in faster growing emerging markets, particularly in Latin America, are viewed as structural drivers that can underpin above category growth over time.
  • Improving mix and pricing actions are expected to support margin resilience. Bullish analysts see this as a potential catalyst for earnings recovery and multiple stabilization once volume trends normalize.

Bearish Takeaways

  • Bearish analysts emphasize muted and decelerating growth in key personal care categories, which raises concern about the company’s ability to consistently deliver mid single digit organic sales growth.
  • Ongoing category headwinds and broad estimate cuts across consumer staples leave limited room for execution missteps, increasing the risk that earnings expectations will need to be revised lower again.
  • Some see the current valuation as only partially reflecting category and macro uncertainty, arguing that downside remains if volume recovery is slower or if promotional intensity rises.
  • Neutral stances highlight that while the franchise is high quality, near term growth constraints and limited upside to current earnings forecasts cap the potential for multiple expansion.

What's in the News

  • Updated 2025 outlook now calls for net sales to grow at a low single digit rate, including a flat to low single digit negative impact from foreign exchange, signaling more cautious topline expectations (company guidance).
  • The company trimmed its 2025 organic sales growth forecast to 1% to 2%, roughly in line with year to date organic growth of 1.2%, down from prior guidance of 2% to 4%. This reflects softer underlying demand and the impact of strategic exits (company guidance).
  • Guidance incorporates about a 70 basis point drag from Colgate-Palmolive’s exit from private label pet sales, underscoring a continued focus on higher margin branded offerings (company guidance).
  • Between July 1 and September 30, 2025, Colgate-Palmolive repurchased 3,052,859 shares for $258.6 million, bringing total buybacks under the March 20, 2025 authorization to 5,887,029 shares for $515.76 million, or 0.73% of shares outstanding (buyback update).

Valuation Changes

  • Fair Value: Unchanged at approximately $87.21 per share, indicating no material shift in intrinsic value estimates.
  • Discount Rate: Edged down slightly from 6.96% to 6.96%, implying a marginally lower required return in the valuation model.
  • Revenue Growth: Essentially unchanged at about 3.39% annually, reflecting stable long term topline growth assumptions.
  • Net Profit Margin: Remained effectively flat at roughly 15.60%, signaling no meaningful revision to long run profitability expectations.
  • Future P/E: Held steady at around 24.3x, suggesting no change in the forward earnings multiple applied in the valuation framework.

Key Takeaways

  • Expansion in oral care and focus on emerging markets, with premiumization and innovation, drive sustained volume growth and strengthen global brand positioning.
  • Investment in AI, digital transformation, and productivity boosts efficiencies, enabling reinvestment into growth and supporting stable margins and resilience against market cycles.
  • Persistent cost pressures, cautious consumer behavior, and competitive challenges in major markets are constraining margin expansion, topline growth, and long-term revenue prospects.

Catalysts

About Colgate-Palmolive
    Manufactures and sells consumer products in the United States and internationally.
What are the underlying business or industry changes driving this perspective?
  • Expansion and premiumization of core oral care lines like Colgate Total, coupled with the roll-out of complementary products across 75 markets, are set to capture increased value from emerging middle-class consumers and rising health/hygiene awareness globally-supporting top-line organic sales acceleration and improved pricing power.
  • Emerging markets such as India, Latin America, and Southeast Asia-where rising incomes and urbanization are growing the addressable customer base-remain a strategic focus with stepped-up innovation, brand investment, and price tiering, sustaining long-term volume and revenue growth.
  • Continued investments in AI, digital transformation, and omnichannel demand generation are expected to enhance operational efficiency, customer reach, and data-driven marketing, translating into greater sales effectiveness and margin resilience.
  • Productivity and restructuring initiatives ($200–$300 million over three years) are designed to free up resources for innovation, digital, and R&D investments, enabling incremental margin expansion and additional reinvestment for growth.
  • Category stabilization and long-term brand strength, particularly in daily-use, trusted segments (oral care, pet nutrition), position Colgate-Palmolive to outperform peers as consumer confidence rebounds, supporting consistent earnings growth and de-risking revenue from cyclical downturns.

Colgate-Palmolive Earnings and Revenue Growth

Colgate-Palmolive Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Colgate-Palmolive's revenue will grow by 3.8% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 14.5% today to 15.5% in 3 years time.
  • Analysts expect earnings to reach $3.5 billion (and earnings per share of $4.43) by about September 2028, up from $2.9 billion today.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 26.1x on those 2028 earnings, up from 23.4x today. This future PE is greater than the current PE for the US Household Products industry at 21.6x.
  • Analysts expect the number of shares outstanding to decline by 1.08% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 6.78%, as per the Simply Wall St company report.

Colgate-Palmolive Future Earnings Per Share Growth

Colgate-Palmolive Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Consumer caution and category softness in key markets like North America, Brazil, and India could persist due to elevated food inflation and macroeconomic uncertainty, potentially constraining volume growth and revenue.
  • Rising raw material and packaging costs, particularly for palm oil and fats, are significantly impacting gross margin, and relief is uncertain, posing ongoing pressure on net margins and profitability.
  • Increased focus on price pack architecture and value offerings in response to cautious consumers and lower category inflation may limit the company's ability to drive premium pricing, potentially compressing margins and slowing topline growth.
  • Company performance in China and India is being challenged by local market dynamics, with China's Hawley & Hazel business requiring significant repositioning in a highly competitive e-commerce environment and India experiencing urban market sluggishness, both of which could hinder long-term revenue growth in these important markets.
  • Continued exposure to private label competition, especially in the pet food category and key emerging markets, along with the exit from private label production, could negatively impact reported sales growth and overall earnings during the transition period.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of $95.222 for Colgate-Palmolive based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $106.0, and the most bearish reporting a price target of just $83.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $22.4 billion, earnings will come to $3.5 billion, and it would be trading on a PE ratio of 26.1x, assuming you use a discount rate of 6.8%.
  • Given the current share price of $84.28, the analyst price target of $95.22 is 11.5% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Colgate-Palmolive?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives